JP2012502281A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502281A5 JP2012502281A5 JP2011526308A JP2011526308A JP2012502281A5 JP 2012502281 A5 JP2012502281 A5 JP 2012502281A5 JP 2011526308 A JP2011526308 A JP 2011526308A JP 2011526308 A JP2011526308 A JP 2011526308A JP 2012502281 A5 JP2012502281 A5 JP 2012502281A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- individual
- biomarkers
- lung cancer
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000090 biomarker Substances 0.000 claims 24
- 238000000034 method Methods 0.000 claims 23
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 7
- 201000005202 lung cancer Diseases 0.000 claims 7
- 208000020816 lung neoplasm Diseases 0.000 claims 7
- 239000012472 biological sample Substances 0.000 claims 5
- 238000004590 computer program Methods 0.000 claims 4
- 238000003556 assay Methods 0.000 claims 3
- 238000000099 in vitro assay Methods 0.000 claims 3
- 108091023037 Aptamer Proteins 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 230000002380 cytological effect Effects 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 2
- 208000019693 Lung disease Diseases 0.000 claims 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- -1 antibodies Proteins 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 239000002853 nucleic acid probe Substances 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9559308P | 2008-09-09 | 2008-09-09 | |
| US61/095,593 | 2008-09-09 | ||
| US15283709P | 2009-02-16 | 2009-02-16 | |
| US61/152,837 | 2009-02-16 | ||
| PCT/US2009/056399 WO2010030697A1 (en) | 2008-09-09 | 2009-09-09 | Lung cancer biomarkers and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012502281A JP2012502281A (ja) | 2012-01-26 |
| JP2012502281A5 true JP2012502281A5 (enExample) | 2012-09-13 |
| JP5701212B2 JP5701212B2 (ja) | 2015-04-15 |
Family
ID=42005456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526308A Active JP5701212B2 (ja) | 2008-09-09 | 2009-09-09 | 肺癌バイオマーカーとその使用 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2340506B1 (enExample) |
| JP (1) | JP5701212B2 (enExample) |
| KR (1) | KR101658347B1 (enExample) |
| CN (2) | CN104198709A (enExample) |
| AU (2) | AU2009291811B2 (enExample) |
| CA (3) | CA3011730C (enExample) |
| DK (1) | DK2340506T3 (enExample) |
| ES (1) | ES2559758T3 (enExample) |
| GB (1) | GB2478441B (enExample) |
| HK (1) | HK1204062A1 (enExample) |
| HR (1) | HRP20160127T1 (enExample) |
| MX (1) | MX2011002322A (enExample) |
| SI (1) | SI2340506T1 (enExample) |
| WO (1) | WO2010030697A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| ES2703714T3 (es) | 2009-03-12 | 2019-03-12 | Cancer Prevention & Cure Ltd | Métodos de identificación, evaluación, prevención y terapia de enfermedades pulmonares y kits de los mismos, incluida la identificación, evaluación, prevención y terapia de enfermedades en base al género |
| CA2801110C (en) * | 2010-07-09 | 2021-10-05 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CN106198980B (zh) | 2010-08-13 | 2018-09-07 | 私募蛋白质体公司 | 胰腺癌生物标记及其用途 |
| RU2612017C2 (ru) * | 2011-04-07 | 2017-03-01 | Де Скриппс Рисерч Инститьют | Высокопроизводительный скрининг соединений, модулирующих экспрессию клеточных макромолекул |
| EP2702411A4 (en) * | 2011-04-29 | 2015-07-22 | Cancer Prevention & Cure Ltd | METHOD FOR IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREFOR |
| JP5986638B2 (ja) * | 2011-10-24 | 2016-09-06 | ソマロジック・インコーポレーテッド | 肺癌バイオマーカーおよびその使用 |
| CA2860298A1 (en) | 2011-12-21 | 2013-06-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| US9304137B2 (en) | 2011-12-21 | 2016-04-05 | Integrated Diagnostics, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| US11913957B2 (en) | 2011-12-21 | 2024-02-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| EP2815343A2 (en) * | 2012-02-17 | 2014-12-24 | Koninklijke Philips N.V. | Acute lung injury (ali)/acute respiratory distress syndrome (ards) assessment and monitoring |
| CN104812913B (zh) | 2012-11-07 | 2019-03-15 | 私募蛋白质体公司 | 慢性阻塞性肺疾病(copd)生物标记及其用途 |
| BR112016010322A2 (pt) * | 2013-11-07 | 2017-08-08 | Medial Res Ltd | Método computadorizado de avaliação de risco de câncer de pulmão, meio legível por computador, sistema de avaliação de câncer de pulmão, e método de geração de um classificador para avaliação de risco de câncer de pulmão |
| JP6857185B2 (ja) * | 2015-09-11 | 2021-04-14 | アプタマー サイエンス インコーポレイテッドＡｐｔａｍｅｒ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． | 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法 |
| FR3050269B1 (fr) | 2016-04-15 | 2018-05-11 | Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) | Procede de selection et de recuperation de produits et systeme associe |
| CN105823665A (zh) * | 2016-05-13 | 2016-08-03 | 北京九州柏林生物科技有限公司 | 生物组织样本制备套液 |
| CA3026809A1 (en) | 2016-06-21 | 2017-12-28 | The Wistar Institute Of Anatomy And Biology | Compositions and methods for diagnosing lung cancers using gene expression profiles |
| JP6280997B1 (ja) * | 2016-10-31 | 2018-02-14 | 株式会社Preferred Networks | 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法 |
| CN110709936A (zh) | 2017-04-04 | 2020-01-17 | 肺癌蛋白质组学有限责任公司 | 用于早期肺癌预后的基于血浆的蛋白质概况分析 |
| EP3676393A4 (en) | 2017-09-01 | 2021-10-13 | Venn Biosciences Corporation | IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING |
| US11885815B2 (en) * | 2017-11-22 | 2024-01-30 | Gritstone Bio, Inc. | Reducing junction epitope presentation for neoantigens |
| EP3728630A4 (en) | 2017-12-19 | 2021-11-17 | The Wistar Institute Of Anatomy And Biology | COMPOSITIONS AND METHODS OF DIAGNOSING LUNG CANCER USING GENE EXPRESSION PROFILES |
| JP7526102B2 (ja) * | 2018-06-22 | 2024-07-31 | ソマロジック・オペレイティング・カンパニー・インコーポレイテッド | 改良されたプロテオミクスマルチプレックスアッセイ |
| WO2020256640A1 (en) * | 2019-06-21 | 2020-12-24 | National University Of Singapore | Methods for determining the likelihood of lung cancer |
| CN110579611B (zh) * | 2019-09-18 | 2023-01-31 | 郑州大学 | 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法 |
| CN111047609B (zh) * | 2020-03-13 | 2020-07-24 | 北京深睿博联科技有限责任公司 | 肺炎病灶分割方法和装置 |
| CN113960235B (zh) * | 2020-10-10 | 2023-03-14 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 生物标志物在制备肺癌检测试剂中的用途和方法 |
| CN112557514B (zh) * | 2020-12-22 | 2021-09-21 | 中国海洋大学 | 手持式海底沉积物样品剖面声学全自动测量装置 |
| WO2025137139A1 (en) * | 2023-12-18 | 2025-06-26 | Caris Mpi, Inc. | Dynamic tissue typing |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596503B1 (en) * | 2000-08-18 | 2003-07-22 | East Carolina University | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| EP1373896A2 (en) * | 2001-03-12 | 2004-01-02 | MonoGen, Inc. | Cell-based detection and differentiation of disease states |
| JP2005527180A (ja) * | 2001-04-18 | 2005-09-15 | プロテイン デザイン ラブス， インコーポレイテッド | 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法 |
| WO2004061410A2 (en) * | 2002-12-18 | 2004-07-22 | Ciphergen Biosystems, Inc. | Serum biomarkers in lung cancer |
| CN1225477C (zh) * | 2003-03-28 | 2005-11-02 | 上海市疾病预防控制中心 | 肺癌早期血清特异蛋白及其应用 |
| CN1455257A (zh) * | 2003-05-23 | 2003-11-12 | 北京师范大学 | 一种利用表面修饰蛋白芯片进行肺癌诊断方法 |
| TW200600785A (en) * | 2004-03-23 | 2006-01-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancer |
| JP2005304497A (ja) * | 2004-03-25 | 2005-11-04 | Joji Inasawa | 特定の癌関連遺伝子を用いる癌の検出方法及び癌の抑制方法 |
| JP4885122B2 (ja) * | 2004-04-15 | 2012-02-29 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 癌、器官傷害、および筋肉リハビリテーション／運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー |
| WO2005103281A2 (en) * | 2004-04-26 | 2005-11-03 | Children's Medical Center Corporation | Platelet biomarkers for the detection of disease |
| KR20070043868A (ko) * | 2004-08-02 | 2007-04-25 | 칠드런'즈 메디컬 센터 코포레이션 | 암에 대한 혈소판 바이오마커 |
| CN1873417A (zh) * | 2005-06-02 | 2006-12-06 | 中国医学科学院肿瘤医院肿瘤研究所 | 一种用于诊断肺癌的蛋白质芯片 |
| EP3153860A3 (en) * | 2005-12-22 | 2017-06-14 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
| US7908091B2 (en) * | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| AU2007313551A1 (en) * | 2006-10-17 | 2008-04-24 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
| US20110119776A1 (en) * | 2007-02-05 | 2011-05-19 | Wong Kwok-Kin | Methods of diagnosing and prognosing lung cancer |
| KR100846354B1 (ko) * | 2007-03-21 | 2008-07-15 | (주) 프로탄바이오 | 혈청 당단백질부터 분리한 폐암 진단용 마커 |
| US20100184773A1 (en) * | 2007-05-18 | 2010-07-22 | Heinz-Josef Lenz | Germline Polymorphisms in the Angiogenic Pathway Predict Tumor Recurrence in Cancer Therapy |
| WO2009036123A1 (en) * | 2007-09-11 | 2009-03-19 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| WO2010003772A1 (en) * | 2008-06-16 | 2010-01-14 | Siemens Medical Solutions Diagnostics Gmbh | Method for predicting adverse response to erythropoietin in breast cancer treatment |
| US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CN102906275A (zh) * | 2010-02-10 | 2013-01-30 | 加利福尼亚大学董事会 | 肺癌检测的唾液生物标记 |
-
2009
- 2009-09-09 SI SI200931363T patent/SI2340506T1/sl unknown
- 2009-09-09 CA CA3011730A patent/CA3011730C/en active Active
- 2009-09-09 EP EP09813557.7A patent/EP2340506B1/en active Active
- 2009-09-09 JP JP2011526308A patent/JP5701212B2/ja active Active
- 2009-09-09 CA CA2734535A patent/CA2734535C/en active Active
- 2009-09-09 CN CN201410477840.7A patent/CN104198709A/zh active Pending
- 2009-09-09 AU AU2009291811A patent/AU2009291811B2/en active Active
- 2009-09-09 DK DK09813557.7T patent/DK2340506T3/en active
- 2009-09-09 WO PCT/US2009/056399 patent/WO2010030697A1/en not_active Ceased
- 2009-09-09 CA CA3152591A patent/CA3152591C/en active Active
- 2009-09-09 HR HRP20160127TT patent/HRP20160127T1/hr unknown
- 2009-09-09 GB GB1106053.0A patent/GB2478441B/en active Active
- 2009-09-09 MX MX2011002322A patent/MX2011002322A/es active IP Right Grant
- 2009-09-09 CN CN200980144620.XA patent/CN102209968B/zh active Active
- 2009-09-09 ES ES09813557.7T patent/ES2559758T3/es active Active
- 2009-09-09 KR KR1020117005305A patent/KR101658347B1/ko active Active
-
2015
- 2015-05-18 HK HK15104677.5A patent/HK1204062A1/xx unknown
- 2015-10-29 AU AU2015249113A patent/AU2015249113B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502281A5 (enExample) | ||
| JP2013532295A5 (enExample) | ||
| Liberto et al. | Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review | |
| CN105143887B (zh) | 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途 | |
| CN103890586B (zh) | 肺癌生物标记及其用途 | |
| JP2022519897A (ja) | 対象の妊娠関連状態を決定するための方法及びシステム | |
| CN108603887B (zh) | 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途 | |
| JP7680950B2 (ja) | 生存分析によるクラス不均衡セットのダウンサンプリングを組み合わせた疾患リスクを判定するための方法 | |
| HRP20160127T1 (hr) | Biomarkeri raka pluä†a i njihove uporabe | |
| Fu et al. | Liquid biopsy technologies for hematological diseases | |
| US9103837B2 (en) | Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof | |
| Meng et al. | Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19 | |
| JP2015514227A5 (enExample) | ||
| Ross et al. | Host-based diagnostics for acute respiratory infections | |
| KR20180036787A (ko) | 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법 | |
| CN115066616A (zh) | 非酒精性脂肪性肝炎(nash)生物标志物及其用途 | |
| CN113718026A (zh) | 用于糖尿病肾脏病变疾病诊断的试剂、产品及其应用 | |
| Phan et al. | Improving the efficiency of biomarker identification using biological knowledge | |
| EP3295176A1 (en) | Biomarkers for detection of tuberculosis risk | |
| CN120555588B (zh) | 用于诊断或辅助诊断hiv合并高脂血症的生物标志物及其应用 | |
| CN120446499B (zh) | 蛋白标志物在制备2型糖尿病发病预测的试剂、试剂盒或装置中的应用 | |
| JP7792338B2 (ja) | 耐糖能異常障害を決定する方法 | |
| US20250290149A1 (en) | Systems and methods for enriching cell-free microbial nucleic acid molecules | |
| HK40090190A (zh) | 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途 | |
| HK40078108A (en) | Nonalcoholic steatohepatitis (nash) biomarkers and uses thereof |